PTC Therapeutics director Michael Schmertzler reports $158,653 common share sale
PTCT•Director Michael Schmertzler disclosed sales of 2,500 PTC Therapeutics common shares on Oct. 7, 2026, for $158,653. His indirect stake fell to 1,294,094 shares.
1. Share sale details
Schmertzler sold 2,500 common shares at prices of $63.38 and $63.95. His indirect stake fell to 1,294,094 shares following the transactions.
